Galectin-3 Impairs Calcium Transients and Β-Cell Function

Qian Jiang,Qijin Zhao,Yibing Chen,Chunxiao Ma,Xiaohong Peng,Xi Wu,Xingfeng Liu,Ruoran Wang,Shaocong Hou,Lijuan Kong,Yanjun Wan,Shusen Wang,Zhuo-Xian Meng,Bing Cui,Liangyi Chen,Pingping Li

DOI: https://doi.org/10.1038/s41467-024-47959-1

2024-01-01

Abstract:In diabetes, macrophages and inflammation are increased in the islets, along with β-cell dysfunction. Here, we demonstrate that galectin-3 (Gal3), mainly produced and secreted by macrophages, is elevated in islets from both high-fat diet (HFD)-fed and diabetic db/db mice. Gal3 acutely reduces glucose-stimulated insulin secretion (GSIS) in β-cell lines and primary islets in mice and humans. Importantly, Gal3 binds to calcium voltage-gated channel auxiliary subunit gamma 1 (CACNG1) and inhibits calcium influx via the cytomembrane and subsequent GSIS. β-Cell CACNG1 deficiency phenocopies Gal3 treatment. Inhibition of Gal3 through either genetic or pharmacologic loss of function improves GSIS and glucose homeostasis in both HFD-fed and db/db mice. All animal findings are applicable to male mice. Here we show a role of Gal3 in pancreatic β-cell dysfunction, and Gal3 could be a therapeutic target for the treatment of type 2 diabetes.